Turn Therapeutics Inc. TTRX
9.48 USD +0.54 (+6.04%)
At closeNov 6, 2026, 4:00 PM EST
9.48 0.00 0.00%
After hours · Nov 6, 4:00 PM ET
8.78 Day range 9.69
2.71 52-week range 15.34
- YTD
- +140.61%
- 1 year
- +123.06%
- Market cap
- 287.89M
- EPS (ttm)
- -0.29
- YTD return
- +140.61%
- 1-year return
- +123.06%
- Volume
- 98.14K
- Avg volume
- 110.70K
- Open
- 9.13
- Previous close
- 8.94
- Day's range
- 8.78 – 9.69
- 52-week range
- 2.71 – 15.34
2Y +2.48 (+35.43%)
Financials — quick view
TTRX Revenue — quarterly 0
TTRX Net income — quarterly -5.85M
TTRX EPS — quarterly -0.20
News
Turn Therapeutics' GX-03 Earns “Developmental Immunology Solution of the Year” in 2026 BioTech Breakthrough Awards Program 
This Tesla Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday 
This Allegion Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday 
WBB Securities Upgrades Turn Therapeutics to Hold, Maintains Price Target to $10 
This Ares Management Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - LUCID CAPITAL MARKETS Initiates Coverage On Turn Therapeutics with Buy Rating, Announces Price Target of $24
WBB Securities Downgrades Turn Therapeutics to Sell, Announces $10 Price Target 
12 Health Care Stocks Moving In Friday's After-Market Session 
12 Health Care Stocks Moving In Tuesday's Intraday Session 
Turn Therapeutics Publishes Peer-Reviewed Research Of GX-03 In Life.
Your note
Sign in to keep a note on TTRX — it syncs with the Stock Master app.